Cisco stock ends week little changed as Cisco flags critical email-security fix, AI Summit next

Cisco stock ends week little changed as Cisco flags critical email-security fix, AI Summit next

New York, January 17, 2026, 12:04 EST — The market is now closed.

  • Cisco stock (CSCO) closed Friday slightly lower, down 0.08% at $75.19
  • Cisco announced software updates addressing a “critical” email-security flaw connected to an ongoing attack campaign
  • Investors are turning toward the AI Summit on Feb. 3 and the company’s upcoming quarterly results, due Feb. 11

Cisco Systems Inc shares slipped 0.08% to $75.19 on Friday, as the market geared up for a lengthy U.S. holiday weekend. Investors focused on a recent security update and several upcoming company events.

The stock’s shift was small, yet the context remains heavy. Cisco provides networking and security equipment to major enterprises, and investors are swift to react to any signal suggesting broader operational risks—or, conversely, an influx of forced upgrades.

Cisco announced software updates to fix a critical vulnerability linked to an ongoing attack targeting certain Secure Email Gateway and Secure Email and Web Manager devices. The flaw lets attackers execute code remotely with “root” privileges, the system’s highest level. Cisco warned customers to update immediately, noting it detected a persistence mechanism—a backdoor intended to maintain access. (Cisco)

U.S. stocks mostly meandered on Friday, with Cisco moving more in line with the broader market than due to any company-specific news. The S&P 500 edged down 0.1%, and the Dow closed just below flat, slipping less than 0.1%, according to the Associated Press. (AP News)

Cisco took the week to announce its second annual AI Summit, scheduled for Feb. 3 in San Francisco and online. The lineup features Nvidia CEO Jensen Huang and OpenAI CEO Sam Altman, with Cisco CEO Chuck Robbins and product chief Jeetu Patel hosting. (Cisco Newsroom)

“Jeetu Patel and I are incredibly excited to be hosting our Cisco AI Summit,” Robbins said in a LinkedIn post about the event. (LinkedIn)

Cisco jumped 1.9% Thursday morning, pushing the Dow higher alongside Nvidia, which together drove much of the index’s gain, MarketWatch reported. The stock had already surged the previous day. (MarketWatch)

On Friday, Cisco submitted a more standard filing. Its investor relations site listed an S-8 registration statement — the form for registering shares linked to employee benefit plans — dated Jan. 16. (Cisco Investor Relations)

Other cybersecurity stocks also dipped on Friday. Fortinet dropped 1.23%, while CrowdStrike and Palo Alto Networks saw smaller declines. Cisco edged down 0.08%, according to MarketWatch data. (MarketWatch)

Equity investors are now eyeing earnings as the next major trigger. Cisco is set to release its quarterly results on Feb. 11, per Zacks. (Zacks)

The risk scenario is complicated. A serious security flaw might stay under control — or spiral into customer losses, rising support expenses, or reputational hits that affect future orders. Meanwhile, an AI-driven event lineup can intensify the narrative without shifting the core numbers investors focus on.

Markets remain closed Monday for Martin Luther King Jr. Day, reopening Tuesday for regular trading. Investors have a moment to digest Cisco’s latest security guidance and monitor any updates before focus turns to the Feb. 3 AI Summit livestream. (Nasdaq)

Stock Market Today

  • Definium Therapeutics (DFTX) Undervalued by DCF After 1-Year 110% Surge
    January 17, 2026, 12:44 PM EST. Definium Therapeutics (DFTX) has jumped about 110% over the past year and trades around $15.05. A Simply Wall St valuation snapshot gives a 2/6 score, signalling limited undervaluation from some checks. The report applies a 2-stage Free Cash Flow to Equity (FCFE) Discounted Cash Flow (DCF) model. It projects negative FCF in the last 12 months and an eventual positive stream through 2030, yielding an intrinsic value of about $234.95 per share. Compared with the current price, that implies the stock is roughly 93.6% undervalued under this setup. The takeaway: momentum may outpace fundamentals, but the base-case relies on volatile profits and pipeline milestones. Investors should weigh the potential value against risk factors and biotech sector dynamics.
Chevron stock: Venezuela license shift and Leviathan gas bet put CVX back on watch
Previous Story

Chevron stock: Venezuela license shift and Leviathan gas bet put CVX back on watch

UnitedHealth stock price falls into holiday-short week as Trump health plan raises stakes for UNH earnings
Next Story

UnitedHealth stock price falls into holiday-short week as Trump health plan raises stakes for UNH earnings

Go toTop